MPR

Colorectal Cancer Screening Uptake Higher With FIT-DNA Than FIT

Patients received either mailed FIT with automated text message outreach from study personnel or mailed FIT-DNA with the ...
MPR

AGA Clinical Practice Update Provided for Diagnosis, Treatment of Hemorrhoids

Dietary and lifestyle modifications are reasonable first-line therapies for symptomatic hemorrhoids, according to a clinical practice update issued by the American Gastroenterological Association and ...
MPR

Auvelity Gains Approval for Agitation in Alzheimer Disease

The Food and Drug Administration (FDA) has approved Auvelity ® (dextromethorphan HBr and bupropion HCl) for the treatment of agitation associated with dementia due to Alzheimer disease (AD).
MPR

FDA Pauses US Enrollment for Phase 3 Evenamide Schizophrenia Study

The Food and Drug Administration (FDA) has placed a hold on the enrollment of new patients in the phase 3 ENIGMA-TRS 2 study evaluating evenamide in treatment-resistant schizophre ...
MPR

FRONTIER2: Denecimig Prophylaxis Reduces Treated Bleeds in Hemophilia A

Novo Nordisk submitted a BLA to the Food and Drug Administration for denecimig for the treatment of hemophilia A in September 2025.